OPAD vs. SKYE

Last updated Jun 9, 2026

OPAD (Offerpad Solutions Inc.) and SKYE (Skye Bioscience, Inc) are both stocks. OPAD operates in Real Estate - Services (Real Estate), while SKYE operates in Biotechnology (Healthcare). Over the past 5 years, OPAD returned -67.51%/yr vs -54.71%/yr for SKYE. At a 0.11 correlation, their price movements are largely independent.

Performance

OPAD vs. SKYE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Offerpad Solutions Inc. (OPAD) and Skye Bioscience, Inc (SKYE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, OPAD achieves a -55.36% return, which is significantly lower than SKYE's 2.71% return.

OPAD

• 1D: -12.51%
• 1M: -19.39%
• YTD: -55.36%
• 6M: -70.81%
• 1Y: -52.20%
• 3Y*: -61.68%
• 5Y*: -67.51%
• 10Y*: —

SKYE

• 1D: 5.02%
• 1M: -10.75%
• YTD: 2.71%
• 6M: -36.36%
• 1Y: -68.31%
• 3Y*: -41.13%
• 5Y*: -54.71%
• 10Y*: -40.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

OPAD vs. SKYE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
OPAD Offerpad Solutions Inc.	-55.36%	-57.54%	-72.20%	48.39%	-92.80%	-41.82%	0.24%
SKYE Skye Bioscience, Inc	2.71%	-73.51%	4.04%	-32.84%	-68.85%	30.00%	33.33%

Correlation

The correlation between OPAD and SKYE is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (All Time) Calculated using the full available price history since Dec 11, 2020	0.11

Fundamentals

Market Cap OPAD : $24.95M SKYE : $30.55M
EPS OPAD : -$1.16 SKYE : -$1.45
PB Ratio OPAD : 0.54 SKYE : 3.39
Total Revenue (TTM) OPAD : $487.19M SKYE : $0.00
Gross Profit (TTM) OPAD : $37.09M SKYE : -$180.01K
EBITDA (TTM) OPAD : -$29.30M SKYE : $10.92M

Return for Risk

OPAD vs. SKYE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OPAD

OPAD Risk / Return Rank: 38
OPAD Sharpe Ratio Rank: 32
OPAD Sortino Ratio Rank: 56
OPAD Omega Ratio Rank: 51
OPAD Calmar Ratio Rank: 22
OPAD Martin Ratio Rank: 28

SKYE

SKYE Risk / Return Rank: 19
SKYE Sharpe Ratio Rank: 16
SKYE Sortino Ratio Rank: 22
SKYE Omega Ratio Rank: 21
SKYE Calmar Ratio Rank: 12
SKYE Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OPAD vs. SKYE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Offerpad Solutions Inc. (OPAD) and Skye Bioscience, Inc (SKYE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	OPAD	SKYE	Difference
Sharpe ratio: Return per unit of total volatility	-0.25	-0.59	+0.35
Sortino ratio: Return per unit of downside risk	1.01	-0.44	+1.45
Omega ratio: Gain probability vs. loss probability	1.11	0.94	+0.17
Calmar ratio: Return relative to maximum drawdown	-0.57	-0.78	+0.21
Martin ratio: Return relative to average drawdown	-0.77	-1.04	+0.27
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

OPAD vs. SKYE - Sharpe Ratio Comparison

The current OPAD Sharpe Ratio is -0.25, which is higher than the SKYE Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of OPAD and SKYE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	OPAD	SKYE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.25	-0.59	+0.35
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.52	-0.42	-0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.51	-0.36	-0.16

Drawdowns

OPAD vs. SKYE - Drawdown Comparison

The maximum OPAD drawdown since its inception was -99.82%, roughly equal to the maximum SKYE drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for OPAD and SKYE.

Drawdown Indicators

	OPAD	SKYE	Difference
Max Drawdown Largest peak-to-trough decline	-99.82%	-99.96%	+0.14%
Max Drawdown (1Y) Largest decline over 1 year	-91.33%	-87.85%	-3.48%
Max Drawdown (3Y) Largest decline over 3 years	-96.35%	-96.79%	+0.44%
Max Drawdown (5Y) Largest decline over 5 years	-99.82%	-98.66%	-1.16%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.83%	—
Current Drawdown Current decline from peak	-99.82%	-99.94%	+0.12%
Average Drawdown Average peak-to-trough decline	-82.08%	-94.95%	+12.87%
Ulcer Index Depth and duration of drawdowns from previous peaks	68.07%	65.76%	+2.31%

Volatility

OPAD vs. SKYE - Volatility Comparison

Offerpad Solutions Inc. (OPAD) has a higher volatility of 30.56% compared to Skye Bioscience, Inc (SKYE) at 28.64%. This indicates that OPAD's price experiences larger fluctuations and is considered to be riskier than SKYE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	OPAD	SKYE	Difference
Volatility (1M) Calculated over the trailing 1-month period	30.56%	28.64%	+1.92%
Volatility (6M) Calculated over the trailing 6-month period	75.65%	63.38%	+12.27%
Volatility (1Y) Calculated over the trailing 1-year period	210.71%	115.33%	+95.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	131.29%	130.81%	+0.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	125.52%	137.31%	-11.79%

Dividends

OPAD vs. SKYE - Dividend Comparison

Neither OPAD nor SKYE has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both OPAD and SKYE in my portfolio?

OPAD and SKYE have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, OPAD or SKYE?

OPAD has higher volatility (30.56%) compared to SKYE (28.64%). In terms of maximum drawdown, OPAD dropped -99.82% vs SKYE's -99.96%.

Which has better risk-adjusted returns?

OPAD currently has the higher Sharpe Ratio (-0.25 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.